Who Generates Higher Gross Profit? Amgen Inc. or United Therapeutics Corporation

Amgen's Gross Profit Dominance Over United Therapeutics

__timestampAmgen Inc.United Therapeutics Corporation
Wednesday, January 1, 2014156410000001162636000
Thursday, January 1, 2015174350000001396725000
Friday, January 1, 2016188290000001526100000
Sunday, January 1, 2017187800000001619600000
Monday, January 1, 2018196460000001429100000
Tuesday, January 1, 2019190060000001331200000
Wednesday, January 1, 2020192650000001375200000
Friday, January 1, 2021195250000001563000000
Saturday, January 1, 2022199170000001789600000
Sunday, January 1, 2023197750000002070000000
Monday, January 1, 202420566000000
Loading chart...

Unlocking the unknown

Amgen Inc. vs. United Therapeutics Corporation: A Decade of Gross Profit

In the competitive landscape of the pharmaceutical industry, Amgen Inc. and United Therapeutics Corporation have been key players. Over the past decade, from 2014 to 2023, Amgen Inc. consistently outperformed United Therapeutics in terms of gross profit. Amgen's gross profit grew by approximately 26% over this period, peaking at nearly $20 billion in 2022. In contrast, United Therapeutics saw a more modest increase of around 78%, reaching just over $2 billion in 2023.

Key Insights

  • Amgen's Dominance: Amgen's gross profit was consistently over 10 times that of United Therapeutics each year.
  • Growth Trends: While both companies showed growth, United Therapeutics' gross profit increased at a faster rate, albeit from a smaller base.
  • 2023 Milestone: United Therapeutics achieved its highest gross profit in 2023, marking a significant milestone in its financial journey.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025